0
     

Report Added
Report already added
Asia Pacific DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity

Asia Pacific DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity

Asia Pacific DNA sequencing market will grow by 17.4% annually with a total addressable market cap of $ 75,903.7 million over 2022-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.

Highlighted with 29 tables and 56 figures, this 108-page report “Asia Pacific DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Sequencing Services

Based on Sequencing Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sanger Sequencing
•Next Generation Sequencing
•Other Sequencing Types

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sequencing by Synthesis
•Ion Semiconductor Sequencing
•Chain Termination Sequencing
•Pyrosequencing
•Sequencing by Ligation (SBL)
•Single-Molecule Real-Time Sequencing (SMRT)
•Nanopore Sequencing
•Other Technologies

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Biomarker Discovery
•Diagnostics
•Personalized Medicine
•Reproductive Health
•Forensics
•Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Academics and Research Organizations
•Pharmaceutical and Biotechnology Companies
•Hospitals & Clinics
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Japan
•China
•South Korea
•Australia
•India
•Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market22
2.2 Major Growth Drivers24
2.3 Market Restraints and Challenges31
2.4 Emerging Opportunities and Market Trends34
2.5 Porter’s Fiver Forces Analysis38
3 Segmentation of Asia Pacific Market by Offering42
3.1 Market Overview by Offering42
3.2 Instruments44
3.3 Consumables45
3.4 Sequencing Services46
4 Segmentation of Asia Pacific Market by Sequencing Type47
4.1 Market Overview by Sequencing Type47
4.2 Sanger Sequencing49
4.3 Next Generation Sequencing50
4.4 Other Sequencing Types51
5 Segmentation of Asia Pacific Market by Technology52
5.1 Market Overview by Technology52
5.2 Sequencing by Synthesis54
5.3 Ion Semiconductor Sequencing55
5.4 Chain Termination Sequencing56
5.5 Pyrosequencing57
5.6 Sequencing by Ligation (SBL)58
5.7 Single-Molecule Real-Time Sequencing (SMRT)59
5.8 Nanopore Sequencing60
5.9 Other Technologies61
6 Segmentation of Asia Pacific Market by Application62
6.1 Market Overview by Application62
6.2 Biomarker Discovery64
6.3 Diagnostics65
6.4 Personalized Medicine66
6.5 Reproductive Health67
6.6 Forensics68
6.7 Other Applications69
7 Segmentation of Asia Pacific Market by End User70
7.1 Market Overview by End User70
7.2 Academics and Research Organizations72
7.3 Pharmaceutical and Biotechnology Companies73
7.4 Hospitals & Clinics74
7.5 Other End Users75
8 Asia-Pacific Market 2021-2031 by Country76
8.1 Overview of Asia-Pacific Market76
8.2 Japan79
8.3 China82
8.4 Australia84
8.5 India86
8.6 South Korea88
8.7 Rest of APAC Region90
9 Competitive Landscape92
9.1 Overview of Key Vendors92
9.2 New Product Launch, Partnership, Investment, and M&A95
9.3 Company Profiles96
Agilent Technologies Inc.96
BGI Genomics Co., Ltd.98
Bio-Rad Laboratories Inc.99
Danaher Corporation (Integrated DNA Technologies Inc.)100
Eurofins Scientific SE101
F. Hoffmann-La Roche Ltd.102
Illumina Inc.103
Merck KGaA104
Pacific Biosciences of California Inc.105
PerkinElmer Inc.106
Thermo Fisher Scientific Inc.107
RELATED REPORTS108

List of Tables:

Table 1. Snapshot of Asia Pacific DNA Sequencing Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Health Spending by Region, $ bn, 2013-202030
Table 4. Main Product Trends and Market Opportunities in Asia Pacific DNA Sequencing Market34
Table 5. Asia Pacific DNA Sequencing Market by Offering, 2021-2031, $ mn42
Table 6. Asia Pacific DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn47
Table 7. Asia Pacific DNA Sequencing Market by Technology, 2021-2031, $ mn52
Table 8. Asia Pacific DNA Sequencing Market by Application, 2021-2031, $ mn62
Table 9. Asia Pacific DNA Sequencing Market by End User, 2021-2031, $ mn70
Table 10. APAC DNA Sequencing Market by Country, 2021-2031, $ mn77
Table 11. Japan DNA Sequencing Market by Offering, 2021-2031, $ mn81
Table 12. Japan DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn81
Table 13. Japan DNA Sequencing Market by End User, 2021-2031, $ mn81
Table 14. China DNA Sequencing Market by Offering, 2021-2031, $ mn83
Table 15. China DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn83
Table 16. China DNA Sequencing Market by End User, 2021-2031, $ mn83
Table 17. Australia DNA Sequencing Market by Offering, 2021-2031, $ mn85
Table 18. Australia DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn85
Table 19. Australia DNA Sequencing Market by End User, 2021-2031, $ mn85
Table 20. India DNA Sequencing Market by Offering, 2021-2031, $ mn87
Table 21. India DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn87
Table 22. India DNA Sequencing Market by End User, 2021-2031, $ mn87
Table 23. South Korea DNA Sequencing Market by Offering, 2021-2031, $ mn89
Table 24. South Korea DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn89
Table 25. South Korea DNA Sequencing Market by End User, 2021-2031, $ mn89
Table 26. DNA Sequencing Market in Rest of APAC by Country/Region, 2021-2031, $ mn91
Table 27. Agilent Technologies Inc.: Company Snapshot96
Table 28. Agilent Technologies Inc.: Business Segmentation97
Table 29. Agilent Technologies Inc.: Product Portfolio97

Report Title: Asia Pacific DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Forecast to 2029

HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029

Medical Aesthetics Market by Product (Facial Aesthetics, Body Contouring, Cosmetic Implant, Physician Dispensed Cosmeceuticals, Skin Aesthetic, Thread Lift), End User (Hospitals, Clinics, & Medical Spas, Beauty Centers, & Home Care) - Forecast to 2029

Medical Aesthetics Market by Product (Facial Aesthetics, Body Contouring, Cosmetic Implant, Physician Dispensed Cosmeceuticals, Skin Aesthetic, Thread Lift), End User (Hospitals, Clinics, & Medical Spas, Beauty Centers, & Home Care) - Forecast to 2029

United Kingdom Hospital Market, By Ownership (Public v/s Private), By Type (General, Multispecialty, Specialty), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Above 500, 100-500, up to 100), By Region, Competition, Forecast & Opportunities, 2017-2027F

United Kingdom Hospital Market, By Ownership (Public v/s Private), By Type (General, Multispecialty, Specialty), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Above 500, 100-500, up to 100), By Region, Competition, Forecast & Opportunities, 2017-2027F

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems, Low-to-Mid Field MRI Systems, Very-High-Field MRI Systems), By Type (Fixed v/s Mobile), By Architecture (Closed v/s Open), By Source (Import v/s Domestic), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac & Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers & Others), By Region, Competition, Forecast & Opportunities, 2017-2027F

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems, Low-to-Mid Field MRI Systems, Very-High-Field MRI Systems), By Type (Fixed v/s Mobile), By Architecture (Closed v/s Open), By Source (Import v/s Domestic), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac & Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers & Others), By Region, Competition, Forecast & Opportunities, 2017-2027F